Kim H, Eun J, Jang S, Kim J, Jeong J
Genes Genomics. 2024; 47(2):135-155.
PMID: 39643826
DOI: 10.1007/s13258-024-01601-y.
Mars J, Culjkovic-Kraljacic B, Borden K
Nucleus. 2024; 15(1):2360196.
PMID: 38880976
PMC: 11185188.
DOI: 10.1080/19491034.2024.2360196.
Han M, Huang Q, Li X, Chen X, Zhu H, Pan Y
Int J Biol Sci. 2024; 20(4):1238-1255.
PMID: 38385078
PMC: 10878144.
DOI: 10.7150/ijbs.90382.
Haqqani A, Mianoor Z, Star A, Detcheverry F, Delaney C, Stanimirovic D
Biology (Basel). 2023; 12(12).
PMID: 38132326
PMC: 10740654.
DOI: 10.3390/biology12121500.
Qiu L, Jing Q, Li Y, Han J
Mol Biomed. 2023; 4(1):25.
PMID: 37612540
PMC: 10447785.
DOI: 10.1186/s43556-023-00139-x.
Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers.
Vizkeleti L, Spisak S
Cells. 2023; 12(13).
PMID: 37443779
PMC: 10341379.
DOI: 10.3390/cells12131745.
RNA modifications in cancer.
Tang Q, Li L, Wang Y, Wu P, Hou X, Ouyang J
Br J Cancer. 2023; 129(2):204-221.
PMID: 37095185
PMC: 10338518.
DOI: 10.1038/s41416-023-02275-1.
The effects of MYC on tumor immunity and immunotherapy.
Li J, Dong T, Wu Z, Zhu D, Gu H
Cell Death Discov. 2023; 9(1):103.
PMID: 36966168
PMC: 10039951.
DOI: 10.1038/s41420-023-01403-3.
Prognostic value of 12 m7G methylation-related miRNA markers and their correlation with immune infiltration in breast cancer.
Zhang W, Zhang S, Wang Z
Front Oncol. 2022; 12:929363.
PMID: 35992830
PMC: 9389359.
DOI: 10.3389/fonc.2022.929363.
MYC: a complex problem.
Das S, Lewis B, Levens D
Trends Cell Biol. 2022; 33(3):235-246.
PMID: 35963793
PMC: 9911561.
DOI: 10.1016/j.tcb.2022.07.006.
Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients.
Kanke M, Kennedy Ng M, Connelly S, Singh M, Schaner M, Shanahan M
Cell Mol Gastroenterol Hepatol. 2022; 13(6):1717-1740.
PMID: 35158099
PMC: 9046244.
DOI: 10.1016/j.jcmgh.2022.02.005.
MYC Hyperactivates Wnt Signaling in /-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of .
Sehgal P, Lanauze C, Wang X, Hayer K, Torres-Diz M, Leu N
Mol Cancer Res. 2021; 19(12):2003-2014.
PMID: 34593610
PMC: 8642317.
DOI: 10.1158/1541-7786.MCR-21-0666.
To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity.
Borden K, Culjkovic-Kraljacic B, Cowling V
Cell Cycle. 2021; 20(14):1347-1360.
PMID: 34241559
PMC: 8344758.
DOI: 10.1080/15384101.2021.1930929.
MYC protein interactors in gene transcription and cancer.
Lourenco C, Resetca D, Redel C, Lin P, MacDonald A, Ciaccio R
Nat Rev Cancer. 2021; 21(9):579-591.
PMID: 34188192
DOI: 10.1038/s41568-021-00367-9.
Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation.
Galloway A, Kaskar A, Ditsova D, Atrih A, Yoshikawa H, Gomez-Moreira C
Nucleic Acids Res. 2021; 49(12):6722-6738.
PMID: 34125914
PMC: 8266598.
DOI: 10.1093/nar/gkab465.
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription.
Pellanda P, Dalsass M, Filipuzzi M, Loffreda A, Verrecchia A, Castillo Cano V
EMBO J. 2021; 40(10):e105464.
PMID: 33792944
PMC: 8126922.
DOI: 10.15252/embj.2020105464.
MYC promotes cancer progression by modulating m A modifications to suppress target gene translation.
Wu G, Suo C, Yang Y, Shen S, Sun L, Li S
EMBO Rep. 2021; 22(3):e51519.
PMID: 33426808
PMC: 7926262.
DOI: 10.15252/embr.202051519.
The eukaryotic translation initiation factor eIF4E elevates steady-state mG capping of coding and noncoding transcripts.
Culjkovic-Kraljacic B, Skrabanek L, Revuelta M, Gasiorek J, Cowling V, Cerchietti L
Proc Natl Acad Sci U S A. 2020; 117(43):26773-26783.
PMID: 33055213
PMC: 7604501.
DOI: 10.1073/pnas.2002360117.
Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis.
Chen H, Guo Y, Sun J, Dong J, Bao Q, Zhang X
J Immunol Res. 2020; 2020:2328675.
PMID: 32322592
PMC: 7165331.
DOI: 10.1155/2020/2328675.
Role of RNA modifications in cancer.
Barbieri I, Kouzarides T
Nat Rev Cancer. 2020; 20(6):303-322.
PMID: 32300195
DOI: 10.1038/s41568-020-0253-2.